TITLE

Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics

AUTHOR(S)
Camilleri, Michael
PUB. DATE
November 2009
SOURCE
Digestive Diseases & Sciences;Nov2009, Vol. 54 Issue 11, p2318
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Purpose: Familial aggregation and sibling pair studies suggest there is a genetic contribution to the development of irritable bowel syndrome (IBS). The aim of this study was to review the evidence of genetics in IBS based on genetic epidemiology, studies of association with intermediate phenotypes and pharmacogenetics.Results: Genetic association studies with IBS symptom phenotype have generally provided inconsistent results for many candidate genes investigated, such as SLC6A4, GNB3, and IL-10. There have been no genome-wide association studies in IBS to date. Studies of associations of candidate genes with intermediate phenotypes suggest associations with pathophysiological mechanisms of motor and sensory functions; however, these results also require replication. Pharmacogenetics studies illustrate the potential of genetics to impact on response to therapy, as observed with SLC6A4 and responses to the 5-HT3 antagonist alosetron and the 5-HT4 agonist, tegaserod.Conclusions: While the heritable component and genetics in the complex disorder of IBS are still poorly understood, studies of the associations of spontaneous genetic variations and altered functions may provide novel insights of the mechanisms contributing to the disease.
ACCESSION #
44645845

 

Related Articles

  • ASK DR. ETINGIN.  // Women's Nutrition Connection;Dec2013, Vol. 16 Issue 12, p8 

    The article presents questions and answers related to health including which foods should one avoid when suffering from irritable bowel syndrome and what is nutrigenomics.

  • Identification of a pharmacogenetic effect by linkage disequilibrium mapping. Xu, C. -F.; Lewis, K. F.; Yeo, A. J.; McCarthy, L. C.; Maguire, M. F.; Anwar, Z.; Danoff, T. M.; Roses, A. D.; Purvis, I. J. // Pharmacogenomics Journal;2004, Vol. 4 Issue 6, p374 

    A practical limitation to the identification of genetic profiles predictive of drug-induced adverse events is the number of patients with the adverse event that can be tolerated before the drug is withdrawn. Whole genome screening for regions of linkage disequilibrium (LD) associated with a...

  • What Role Does Wheat Play in the Symptoms of Irritable Bowel Syndrome? Eswaran, Shanti; Goel, Akash; Chey, William D. // Gastroenterology & Hepatology;Feb2013, Vol. 9 Issue 2, p85 

    Recently, increasing attention has been paid to the pathologic role of food in irritable bowel syndrome (IBS). Nevertheless, healthcare providers often avoid addressing diet with their patients because of a lack of training, guideline consensus, and high-quality data. Recent literature supports...

  • T-Cell Activation in Patients With Irritable Bowel Syndrome. Öhman, Lena; Isaksson, Stefan; Lindmark, Ann-Charlotte; Posserud, Iris; Stotzer, P.-O.; Strid, Hans; Sjövall, Henrik; Simrén, Magnus // American Journal of Gastroenterology;May2009, Vol. 104 Issue 5, p1205 

    OBJECTIVES:Irritable bowel syndrome (IBS) has been found to be associated with low-grade immune activation in a subset of patients. We therefore investigated blood and colonic T-cell activity in IBS patients.METHODS:Blood samples were initially obtained from 74 IBS patients and 30 controls....

  • Alteration of GI symptoms in a cow with Johne disease by the dietary organosulfur, 2-mercaptoethanol. Click, Robert E. // Virulence;Oct2012, Vol. 3 Issue 6, p543 

    Sub-phenotypes of inflammatory bowel disease (IBD)--Crohn disease, ulcerative colitis and some cases of irritable bowel syndrome--are generally considered a consequence of gastrointestinal inflammation of unknown etiology. Conventional therapy and more recently biologic agents, all with varying...

  • The value of twins in epigenetic epidemiology. Bell, Jordana T; Saffery, Richard // International Journal of Epidemiology;Feb2012, Vol. 41 Issue 1, p140 

    During past decades, twin studies have played an important role in genetic epidemiology studies of complex traits. The strength of twin studies lies in the ability to disentangle genetic and environmental factors that contribute to a phenotype, by comparing genetically identical monozygotic...

  • Update on Irritable Bowel Syndrome Program of Research. Heitkemper, Margaret; Jarrett, Monica; Sang-Eun, Jun // Journal of Korean Academy of Nursing;2013, Vol. 43 Issue 5, p579 

    Purpose: This article provides an update and overview of a nursing research program focused on understanding the pathophysiology and management of irritable bowel syndrome (IBS). Methods: This review includes English language papers from the United States, Europe, and Asia (e.g., South Korea)...

  • Using HapMap Tools in Pharmacogenomic Discovery: The Thiopurine Methyltransferase Polymorphism. Jones, T. S.; Yang, W.; Evans, W. E.; Relling, M. V. // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p729 

    One purpose of the International HapMap Project is to provide a genome-wide resource to discover pharmacogenetic determinants of drug response. The thiopurine methyltransferase (TPMT) 719A>G single-nucleotide polymorphism (SNP) causes decreased TPMT activity, increased intracellular thiopurines,...

  • A model to investigate SNPs' interaction in GWAS studies. Cocchi, Enrico; Drago, Antonio; Fabbri, Chiara; Serretti, Alessandro // Journal of Neural Transmission;Jan2015, Vol. 122 Issue 1, p145 

    Genome-wide association studies (GWAS) are able to identify the role of individual SNPs in influencing a phenotype. Nevertheless, such analysis is unable to explain the biological complexity of several diseases. We elaborated an algorithm that starting from genes in molecular pathways implicated...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics